[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349646-105":59,"doc-detail-349646-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","serum-cell-free-hpv-human-dna-junction-detection-and-hpv-typing-for-predicting-and-monitoring-cervical-cancer-recurrence","Serum, cell-free, HPV-human DNA junction detection and HPV typing for predicting and monitoring cervical cancer recurrence","","Nearly all cervical cancers are driven by human papillomaviruses (HPVs) with frequent HPV DNA integration into the human genome. This study detects tumor-specific HPV-human DNA junctions in serum cell-free DNA from a subset of cervical cancer patients during initial treatment and/or 6 months post-treatment. Retrospective findings show these junctions are more often present in patients whose cancer later recurred. Cervical cancers linked to HPV types outside clade α9 recur more frequently than α9-linked cancers, supporting serum junction detection and HPV typing as predictors and non-invasive monitoring tools.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/serum-cell-free-hpv-human-dna-junction-detection-and-hpv-typing-for-predicting-and-monitoring-cervical-cancer-recurrence/349646/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/serum-cell-free-hpv-human-dna-junction-detection-and-hpv-typing-for-predicting-and-monitoring-cervical-cancer-recurrence/349646.png","ImageObject",300,407,{"name":92,"@type":93},"pixelkiddo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the study detect in patients with cervical cancer?","Question",{"text":112,"@type":113},"It detects tumor-specific HPV-human DNA junctions in serum cell-free DNA, using samples obtained during initial treatment and/or about 6 months after treatment.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How are the junctions related to recurrence risk?",{"text":117,"@type":113},"Retrospective analysis shows junctions are more frequently detectable in women whose cancer later recurred.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is HPV clade important for recurrence frequency?",{"text":121,"@type":113},"Cancers caused by HPV types outside phylogenetic clade α9 show a higher recurrence frequency than α9-associated cancers, including among comparison with the Cancer Genome Atlas database.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349646,1790179344,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},962090883892,"https://ap-avatar.wpscdn.com/avatar/e00115db34f3e0f11b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1790152879550218658","RESEARCH ARTICLE  \nSerum, cell-free, HPV-human DNA junction detection and HPV typing for predicting and monitoring cervical cancer recurrence  \nAnne R Van Arsdale1,2*, Olga Meshcheryakova1, Sonia Gallego1, Elaine C Maggi1, Bryan Harmon3, Dennis YS Kuo2, Koenraad Van Doorslaer4, Mark H Einstein2, Brian J Haas5, Cristina Montagna1,6*, Jack Lenz1*  \n1 Department of Genetics, Albert Einstein College of Medicine, Bronx, United States; 2 Department of Obstetrics Gynecology and Women’s Health, Albert Einstein College of Medicine, Bronx, United States; 3 Department of Pathology, Albert Einstein College of Medicine, Bronx, United States; 4School of Animal and Comparative Biomedical Sciences, College of Agriculture and Life Sciences BIO5 Institute, University of Arizona, Tucson, United States; 5 Broad Institute, Cambridge, United States; 6 Rutgers Cancer Institute, New Brunswick, United States  \n*For correspondence:  \n[aarsdale@montefiore.org](aarsdale@montefiore.org)[ ](aarsdale@montefiore.org)(ARVA); [cm1469@cinj.rutgers.edu](cm1469@cinj.rutgers.edu) (CM); [jack.lenz@einsteinmed.edu](jack.lenz@einsteinmed.edu) (JL)  \nCompeting interest: The authors declare that no competing interests exist.  \nFunding: See page 13  \nPreprint posted  \n06 January 2025  \nSent for Review  \n03 January 2025  \nReviewed preprint v1  \n26 June 2025  \nVersion of Record  \n09 September 2026  \nReviewing Editor: Lynne-Marie Postovit, Queen's University, Canada  \n Copyright Van Arsdale et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.  \n\n| eLife Assessment\u003Cbr>This is a valuable study that suggests that HPV-human DNA junctions can be identified from cfDNAin women with cervical cancer and that detection of these junctions is indicative of recurrence. The evidence supporting the conclusions is incomplete, in part because the numbers of reads identifying breakpoints in tumor samples or in circulating cell-free serum samples are not provided. More quantitative analysis will be required to confirm that the breakpoints represented in cell-free DNA can be used as a surrogate to monitor the recurrence of cervical cancer cells, and additional patient studies would also be needed to strengthen the study. This work will be of interest to those who study and treat cervical cancer as well as other HPV-related malignancies. |\n| --- |\n| Abstract Almost all cervical cancers are caused by human papillomaviruses (HPVs) . In most cases, HPV DNA is integrated into the human genome. We found that tumor-specific, HPV-human DNA junctions are detectable in serum cell-free DNA of a fraction of cervical cancer patients at the time of initial treatment and/or at 6 months following treatment. Retrospective analysis revealed these junctions were more frequently detectable in women in whom the cancer later recurred. We also found that cervical cancers caused by HPV types outside of phylogenetic clade α9 had a higher recurrence frequency than those caused by α9 types in both our study and The Cancer Genome Atlas cervical cancer database, despite the higher prevalence ofα9 types, including HPV16, in cervical cancer. Thus, HPV-human DNA junction detection in serum cell-free DNA and HPV type determination in tumor tissue may help predict recurrence risk. Screening serum cell-free DNA for junctions may also offer an unambiguous non-invasive means to monitor absence of recurrence following treatment. |\n\nVan Arsdale et al. eLife 2025;14:RP105741. DOI: [https://doi.org/10.7554/eLife.105741](https://doi.org/10.7554/eLife.105741) 1 of 16  \n Research article Cancer Biology  \nIntroduction  \nThe vast majority of cervical cancers are caused by human papillomaviruses (HPVs), and they remain a significant cause of cancer deaths. Despite the availability of HPV vaccines and effective procedures for detecting and treating pre-invasive cervical lesions, they rank a","cbCaigVQgRGd9Osg","https://ap.wps.com/l/cbCaigVQgRGd9Osg","pdf",6455975,16,"English","# Abstract\n# Introduction\n# Results\n## Detection of HPV-human DNA junctions in cervical cancer patient tumors","[{\"question\":\"What does the study detect in patients with cervical cancer?\",\"answer\":\"It detects tumor-specific HPV-human DNA junctions in serum cell-free DNA, using samples obtained during initial treatment and/or about 6 months after treatment.\"},{\"question\":\"How are the junctions related to recurrence risk?\",\"answer\":\"Retrospective analysis shows junctions are more frequently detectable in women whose cancer later recurred.\"},{\"question\":\"Why is HPV clade important for recurrence frequency?\",\"answer\":\"Cancers caused by HPV types outside phylogenetic clade α9 show a higher recurrence frequency than α9-associated cancers, including among comparison with the Cancer Genome Atlas database.\"}]","Serum, cell-free, HPV-human DNA junction detection and HPV typing for predicting and monitoring cervical cancer recurrence | PDF",1790084680,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/36fcbf314201d579f606f50a983500af.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/665dbec69b22bb63536a36676063f84e.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/83169721aee057a086b845fa5985b719.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/58a745257a34821b6d6976a78526cabe.webp",980,1268]